Skip to main content

Table 1 Characteristics of study participants (N = 3,663)

From: Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study

 

Men (N = 1,334, 36.4%)

Women (N = 2,329, 63.6%)

P-valuea

Age (years), mean ± stdb

53.4 ± 13.0

54.5 ± 12.7

.01

Annual household income,%

   

Less than $19,999

19.9

32.3

<.0001

$20,000 - 49,999

32.9

39.2

$50,000 or more

47.2

28.6

Hypertensive, %

57.7

62.1

.008

Systolic blood pressure (mmHg)

127.8 ± 18.1

125.9 ± 18.2

.002

Diastolic blood pressure (mmHg)

81.6 ± 10.4

77.5 ± 10.0

<.0001

Type 2 Diabetic, %

12.6

16.2

.003

Current Smoker,%

16.6

10.4

<.0001

Physical activity score

8.8 ± 2.6

8.3 ± 2.5

<.0001

Alcohol consumer, %

61.7

40.0

<.0001

BMIc (kg/m2)

29.8 ± 6.2

32.8 ± 7.6

<.0001

Fasting insulin (uU/mL)

17.1 ± 30.7

18.8 ± 15.5

.05

LDL-Cholesterold (mg/dL)

128.5 ± 36.6

125.1 ± 36.1

.006

HDL-Cholesterole (mg/dL)

46.0 ± 12.5

55.1 ± 14.4

<.0001

Total Cholesterol (mg/dL)

196.1 ± 39.1

199.8 ± 39.4

.005

HOMA-IRf

3.45 ± 2.42

3.78 ± 2.41

.0002

Fasting Glucose (mg/dl)

99.4 ± 31.4

99.1 ± 30.9

.78

CRPg (mg/dL)

.37 ± 1.09

.59 ± .84

<.0001

Plasma leptin (ng/mL)

11.2 ± 10.6

37.5 ± 23.3

<.0001

Circulating Plasma adiponectin (ug/mL)

4.1 ± 3.3

6.0 ± 4.6

<.0001

Circulating Plasma adiponectin, %

   

≤2.70 ug/mL

38.8

17.5

<.0001

>2.70 - ≤4.2 ug/mL

26.8

23.8

 

>4.2 - ≤6.7 ug/mL

20.3

28.0

 

>6.7 ug/mL

14.1

30.7

 
  1. aTwo sample t-test for continuous variables and chi-square for categorical variables; significance established as P < .05.
  2. bstd = standard deviation. All continuous variables present mean ± deviation.
  3. cBMI = body mass index.
  4. dLDL = low-density lipoprotein.
  5. eHDL = high-density lipoprotein.
  6. fHOMA-IR = homeostasis model assessment – insulin resistance.
  7. gCRP = C-reactive protein.